Sandoz Group AG
SDZ
Kedudukan dalam Saham
#579
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
Harga Saham
$96.21
Modal Pasaran
$41.63B
Perubahan (1 hari)
1.02%
Perubahan (1 tahun)
58.97%
Negara
CH
Perdagangan Sandoz Group AG (SDZ)
Kategori
Healthcare
Pendapatan untuk Sandoz Group AG (SDZ)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Sandoz Group AG, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Sandoz Group AG dari 2020 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2025 | $1.21B | -11,072.73% |
| 2024 | $-11.00M | -108.46% |
| 2023 | $130.00M | -88.20% |
| 2022 | $1.10B | -15.20% |
| 2021 | $1.30B | 85.42% |
| 2020 | $700.85M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
